Skip to content

    Recently Viewed

      Listening...

      Home /
      Vaccines

      Vaccines

      See all stories about vaccines, and learn how Johnson & Johnson is working towards advancing healthcare and health equity with vaccinations.
      Innovation
      what-happens-when-antibiotics-stop-working-1122.jpg

      What happens when antibiotics stop working?

      More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
      Health & wellness
      An influenza virus particle

      4 things to know about the flu in the time of COVID-19

      How can you tell which virus is causing your cough or fever? Is it too late to get a flu shot if you haven’t? A Johnson & Johnson expert addresses these questions—and how the company is working to improve the future of flu prevention.
      Health & wellness
      A mother wipes her son's nose

      4 things to know about RSV in the time of COVID-19

      Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. For National RSV Awareness Month, learn how Johnson & Johnson is working to keep us all safer from RSV.
      Latest news
      A brick wall at Johnson & Johnson's headquarters

      Johnson & Johnson COVID-19 vaccine named one of Time‘s Best Inventions of 2021.

      The vaccine is one of three COVID-19 vaccines sharing joint recognition on the list of groundbreaking innovations this year.
      Latest news
      JNJ-Earns-Spot-on-Fortunes-2021-Change-the-World-List-lede-B.jpg

      Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.

      The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.
      Latest news
      2021 Dr. Paul Janssen Award Winners Katalin Karikó, Ph.D., and Drew Weissman, M.D., Ph.D.

      Two pioneering RNA scientists win the 2021 Dr. Paul Janssen Award for biomedical research

      Learn how their revolutionary work has not only had a crucial impact on the COVID-19 pandemic but is also paving the way for potential future vaccines and treatments.
      Latest news
      lede-Johnson & Johnson Chairman and CEO Appears at the White House to Discuss the Company's Collaboration with Merck and Future Vaccine Production.jpg

      Johnson & Johnson Chairman and CEO appears at the White House to discuss the company’s collaboration with Merck and future vaccine production

      Learn more about the event, Johnson & Johnson’s historic collaboration with Merck—and watch a video that chronicles the progress that the company has made since last March in the fight against COVID-19.
      Our heritage
      Lede-6 Trailblazing Johnson & Johnson Scientists Past and Present.jpg

      6 trailblazing Johnson & Johnson scientists, past and present

      For Women’s History Month, we’re spotlighting three of the company’s pioneering early female scientists—and their modern-day counterparts, who are not only innovating in the lab, but also paving the way for the next generation of powerhouse women.
      Innovation
      A view from inside a secure vaccine laboratory

      From lab to vaccine vial: The historic manufacturing journey of Johnson & Johnson’s Janssen COVID-19 Vaccine

      As the U.S. government announces an agreement between Johnson & Johnson and Merck to collaborate on vaccine production, we trace all the steps it takes—from growing cells in a bioreactor to prepping palettes with high-tech track-and-trace technology—to develop and manufacture a vaccine during a pandemic.
      Latest news
      lede-A Message from Chairman and CEO Alex Gorsky About Johnson & Johnson's Investigational COVID-19 Vaccine Candidate.jpg

      A message from Chairman and CEO Alex Gorsky about the Emergency Use Authorization of Johnson & Johnson’s Janssen COVID-19 vaccine

      The company leader shares the latest news about the U.S. Food and Drug Administration’s decision about the single-shot Janssen COVID-19 vaccine.